SCHEMBL13745224

SCHEMBL13745224

C=C1CCCCC(C(=O)C(=O)OCC)C1=O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.38
KMT2A Q03164 3/20 0.35
TLR4 O00206 1/20 0.34
ALDH1A1 P00352 7/20 0.33
MAPT P10636 4/20 0.33
HPGD P15428 2/20 0.33
MEN1 O00255 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ATM Q13315 1/20 0.33
TSHR P16473 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPK1 P28482 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10080620 0.99 CYP2D6 (0.37) CYP2D6KMT2ATLR4ALDH1A1MAPT
SCHEMBL181879 0.81 CYP2D6 (0.48) CYP2D6KMT2ATLR4ALDH1A1MAPT
SCHEMBL10080626 0.80 CYP2D6 (0.47) CYP2D6KMT2ATLR4ALDH1A1MAPT
SCHEMBL1149626 0.80 CYP2D6 (0.47) CYP2D6KMT2ATLR4ALDH1A1MAPT
SCHEMBL25626839 0.80 BRD4 (0.38) CYP2D6KMT2ATLR4ALDH1A1MAPT
SCHEMBL7776804 0.80 ALDH1A1 (0.45) KMT2ATLR4ALDH1A1MAPTHPGD
SCHEMBL5109918 0.76 CYP2D6 (0.42) CYP2D6KMT2ATLR4ALDH1A1MAPT
SCHEMBL13411534 0.73 ATM (0.36) KMT2AALDH1A1MAPTHPGDMEN1
SCHEMBL13745233 0.72 NPC1 (0.48) KMT2AALDH1A1MAPTHPGDMEN1
SCHEMBL176973 0.72 NPC1 (0.48) KMT2AALDH1A1MAPTHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378096-B2 Hexahydro-cycloheptapyrazole cannabinoid modulators JANSSEN PHARMACEUTICA N.V. (BE) 2013-02-19 US disclosed
US-8378117-B2 1-(4-fluoro-phenyl)-8-(4-methyl-benzyl)-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid (1,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-amide; antidepressant, anxiolytic; nervous system disorders, metabolic disorders, obesity JANSSEN PHARMACEUTICA N.V. (BE) 2013-02-19 US disclosed
US-20090197886-A1 HEXAHYDRO-CYCLOHEPTAPYRAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2009-08-06 US disclosed
US-20080070968-A1 Hexahydro-Cycloheptapyrazole Cannabinoid Modulators JANSSEN PHARMACEUTICA N.V. (BE) 2008-03-20 US disclosed
US-20070123578-A1 Hexahydro-cycloheptapyrazole cannabinoid modulators JANSSEN PHARMACEUTICA N.V. (BE) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197886-A1 HEXAHYDRO-CYCLOHEPTAPYRAZOLE CANNABINOID MODULATORS CNR2, CNR1, FAAH CYP2D6 699/4885KMT2A 2346/4885TLR4 1638/4885
US-20080070968-A1 Hexahydro-Cycloheptapyrazole Cannabinoid Modulators CNR2, CNR1, FAAH CYP2D6 699/4885KMT2A 2346/4885TLR4 1638/4885
US-20070123578-A1 Hexahydro-cycloheptapyrazole cannabinoid modulators CNR2, CNR1, FAAH CYP2D6 699/4885KMT2A 2346/4885TLR4 1638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.